Product
VVN539 Ophthalmic Solution
1 clinical trial
2 indications
Indication
GlaucomaIndication
Open-AngleClinical trial
A Phase 2, Double-masked, Randomized, Vehicle-controlled, Dose-response Study Assessing the Safety and Ocular Hypotensive Efficacy of VVN539 in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionStatus: Completed, Estimated PCD: 2022-12-22